Aimei Health Technology Co., Ltd. Announces the Separate Trading of its Ordinary Shares and Rights Commencing January 22, 2024

NEW YORK, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd. (“Aimei”) announced today that, commencing January 22, 2024, holders of the units sold in the Company’s initial public offering completed on December 6, 2023 may elect to separately trade the ordinary shares of Aimei, and the rights included in such units on The Nasdaq Global Market (“Nasdaq”).

Read more at globenewswire.com